Patient-reported outcomes in patients with type 2 diabetes treated with liraglutide or glimepiride, both as add-on to metformin.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 20444662.
- Also identified by DOI 10.1016/j.pcd.2010.04.001.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Patient-reported outcomes for liraglutide or glimepiride on metformin were investigated. Patients' treatment satisfaction on liraglutide was higher than with metformin alone and comparable with glimepiride+metformin. Patients perceived lower frequency of hypoglycaemia than glimepiride+metformin and lower frequency of hyperglycaemia than metformin. Impact of weight on quality of life did not differ.
Medical subject headings
- Diabetes Mellitus, Type 2
- Glucagon-Like Peptide 1
- Hypoglycemic Agents
- Metformin
- Sulfonylurea Compounds